Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: A systematic review and meta‐analysis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
It has been hypothesized that polymorphisms in the vitamin D receptor (VDR) gene affect the risk of developing melanoma. However, results often are conflicting, and no meta‐analysis has been performed to date on published data. Six studies (cases, 2152; controls, 2410) that investigated the association between 5 VDR polymorphisms (TaqI, FokI, BsmI, EcoRV, and Cdx2) and the risk of melanoma were retrieved and analyzed. The model‐free approach was applied to meta‐analyze these molecular association studies. Available data suggested a significant association between the BsmI VDR polymorphism and melanoma risk (pooled odds ratio [OR], 1.30; 95% confidence interval [CI], 1.11‐1.53; P = .002; heterogeneity Cochran Q test, P > .1), and the population‐attributable risk was 9.2%. In contrast, the FokI polymorphism did not appear to be associated with such risk (OR, 1.09; 95% CI, 0.99‐1.21; P = .07; heterogeneity Cochran Q test, P > .1). For the TaqI and the EcoRV polymorphisms, significant between‐study heterogeneity did not support genotype data pooling. Only 1 study investigated the Cdx2 variant, and the findings were negative. Current evidence is in favor of an association between 1 VDR gene polymorphism (BsmI) and the risk of developing melanoma. The current findings prompt further investigation on this subject andindirectly support the hypothesis that sun exposure may have an antimelanoma effect through activation of the vitamin D system. Cancer 2008. © 2008 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure
Gandini, S., Sera, F., Cattaruzza, M. S., Pasquini, P., Picconi, O., Boyle, P., & Melchi, C. F. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.10.016 · Cited by 1,266
Transcriptional regulation of Th1/Th2 polarization
Rengarajan, J., Szabo, S. J., & Glimcher, L. H. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01712-6 · Cited by 433
Polymorphisms in the MTHFR and VDR genes and skin cancer risk
Han, J., Colditz, G. A., & Hunter, D. J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl156 · Cited by 110
Cited by
Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions
Bouillon, R., Marcocci, C., Carmeliet, G., Bikle, D., White, J. H., Dawson-Hughes, B., Lips, P., Munns, C. F., Lazaretti-Castro, M., Giustina, A., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00126 · Cited by 1,143
Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk
Raimondi, S., Johansson, H., Maisonneuve, P., & Gandini, S. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp103 · Cited by 265
Slominski, A. T., Brożyna, A. A., Zmijewski, M. A., Jóźwicki, W., Jetten, A. M., Mason, R. S., Tuckey, R. C., & Elmets, C. A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.3 · Cited by 136
Expression of vitamin D receptor decreases during progression of pigmented skin lesions
Brożyna, A. A., Jozwicki, W., Janjetovic, Z., & Slominski, A. T. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.09.014 · Cited by 120
Ogbah, Z., Visa, L., Badenas, C., Ríos, J., Puig-Butille, J. A., Bonifaci, N., Guino, E., Augé, J. M., Kolm, I., Carrera, C., et al. (2013) · BMC Medical Genetics · doi:10.1186/1471-2350-14-26 · Cited by 28
Metadata
- Authors
- Mocellin, S., & Nitti, D.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-10-17
- Volume
- 113
- Issue
- 9
- Pages
- 2398-2407
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2042101905
- Cited by
- 71
- References
- 3
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.